- Investing Ideas
- Belgian Pharmaceuticals & Biotech Potentially Undervalued Companies
Belgian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
2
0 new
Companies with a Value score of at least 3, ordered by Value score
2 companies
UCB
Market Cap: €46.8b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€250.20
7D
2.6%
1Y
35.2%
argenx
Market Cap: €49.4b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€772.00
7D
1.6%
1Y
50.1%